Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2008 by Rabin Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Rabin Medical Center
ClinicalTrials.gov Identifier:
NCT00737659
First received: August 17, 2008
Last updated: March 25, 2010
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)